253840 — Sugentech Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapFalling Star

Annual income statement for Sugentech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	77,201	101,399	7,132	10,097	9,417
Cost of Revenue
Gross Profit	48,145	43,861	-4,155	-1,207	811
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	42,386	76,428	31,152	35,490	34,916
Operating Profit	34,816	24,971	-24,020	-25,393	-25,500
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	43,310	32,322	-18,722	-20,785	-23,420
Provision for Income Taxes
Net Income After Taxes	36,150	26,678	-17,378	-15,370	-23,492
Minority Interest
Net Income Before Extraordinary Items
Net Income	36,152	26,717	-17,238	-15,193	-23,314
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	36,152	26,717	-17,238	-15,193	-23,314
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2,160	1,481	-1,034	-851	-1,236
Dividends per Share